EDGAR Filing Documents for 0001104659-23-032020

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001104659-23-032020

Filing Date

2023-03-14

Accepted

2023-03-14 06:47:14

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	424B5	tm239060-2_424b5.htm	424B5	521485
2	GRAPHIC	lg_nrx-4clr.jpg	GRAPHIC	44375
	Complete submission text file	0001104659-23-032020.txt		583458

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801

Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134

NRX Pharmaceuticals, Inc. (Filer) CIK: 0001719406 (see all company filings)